Aveanna Healthcare Holdings Inc Stock

$4.90

2.90% today

Nasdaq, Feb 05, 04:14 pm CET

ISIN

US05356F1057

Symbol

AVAH

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Health service provider

Overview Dividends Analysts Charts News Strategies

Aveanna Healthcare Holdings Inc Stock price

$4.76

-6.77 58.72% 5Y

Nasdaq, Closing price Tue, Feb 04 2025

+0.14 3.03%

ISIN

US05356F1057

Symbol

AVAH

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Health service provider

Key metrics

Market capitalization	$919.75m
Enterprise Value	$2.17b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	220.30
EV/Sales (TTM) EV/Sales	1.10
P/S ratio (TTM) P/S ratio	0.46
P/B ratio (TTM) P/B ratio	negative
Revenue growth (TTM) Revenue growth	6.21%
Revenue (TTM) Revenue	$1.98b
EBIT (operating result TTM) EBIT	$134.77m
Free Cash Flow (TTM) Free Cash Flow	$9.87m
Cash position	$78.46m
EPS (TTM) EPS	$-0.34
P/E forward	negative
P/S forward	0.46
EV/Sales forward	1.08
Short interest	2.38%

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Get Started for Free Today

Aveanna Healthcare Holdings Inc Stock Analysis

Unlock Scores for Free

??

8 Analysts have issued a Aveanna Healthcare Holdings Inc forecast:

5x Hold

63%

2x Sell

25%

More details on Analyst Estimates Including Price Targets

8 Analysts have issued a Aveanna Healthcare Holdings Inc forecast:

Buy

13%

Hold

63%

Sell

25%

Analyst Estimates with Stock Price Targets

Financial data from Aveanna Healthcare Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	1,983 1,983	6% 6% 100%
- Direct Costs	1,383 1,383	6% 6% 70%
Gross Profit	601 601	7% 7% 30%
- Selling and Administrative Expenses	435 435	3% 3% 22%
- Research and Development Expense	- -	- -
EBITDA	166 166	19% 19% 8%
- Depreciation and Amortization	31 31	4% 4% 2%
EBIT (Operating Income) EBIT	135 135	26% 26% 7%
Net Profit	-66 -66	81% 81% -3%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Aveanna Healthcare Holdings Inc Stock News

Neutral

GlobeNewsWire

●

about one month ago

Aveanna to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

ATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2025.

Neutral

Seeking Alpha

●

3 months ago

Aveanna Healthcare Holdings Inc. (AVAH) Q3 2024 Earnings Call Transcript

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Grayson McAlister - T...

Neutral

GlobeNewsWire

●

3 months ago

Aveanna Healthcare Holdings Announces Third Quarter 2024 Financial Results and Revised 2024 Outlook

ATLANTA, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods September 28, 2024.

More Aveanna Healthcare Holdings Inc News

Company Profile

Aveanna Healthcare Holdings, Inc. operates as a holding company. The firm, through its subsidiaries, provides pediatric home care services. It offers pediatric therapy, adult skilled nursing, and medical services. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA.

Head office	United States
CEO	Jeffery Shaner
Employees	33,500
Founded	2016
Website	www.aveanna.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now